Mark Wong

456 total citations
11 papers, 103 citations indexed

About

Mark Wong is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Mark Wong has authored 11 papers receiving a total of 103 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 8 papers in Hepatology and 4 papers in Surgery. Recurrent topics in Mark Wong's work include Liver Disease and Transplantation (5 papers), Liver Disease Diagnosis and Treatment (5 papers) and Hepatitis B Virus Studies (3 papers). Mark Wong is often cited by papers focused on Liver Disease and Transplantation (5 papers), Liver Disease Diagnosis and Treatment (5 papers) and Hepatitis B Virus Studies (3 papers). Mark Wong collaborates with scholars based in United States. Mark Wong's co-authors include Ester C. Little, Richard Manch, Richard Gerkin, Robert Raschke, Steven C. Curry, Alan I. Leibowitz, Geetha Kolli, James E. Melvin, Nayan Patel and A. Moore and has published in prestigious journals such as Critical Care Medicine, The American Journal of Gastroenterology and Digestive Diseases and Sciences.

In The Last Decade

Mark Wong

9 papers receiving 100 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Wong United States	5	63	37	28	24	18	11	103
Joaquín Plazas Spain	5	40 0.6×	54 1.5×	20 0.7×	4 0.2×	3 0.2×	8	90
Tahar Hadou France	6	80 1.3×	64 1.7×	27 1.0×	2 0.1×	3 0.2×	9	135
Thiruvengadam Vasanthi India	9	15 0.2×	9 0.2×	90 3.2×	12 0.5×	24 1.3×	17	179
Andrea Cona Italy	6	4 0.1×	48 1.3×	16 0.6×	16 0.7×	3 0.2×	19	134
Abhishek Singhai India	7	21 0.3×	46 1.2×	28 1.0×			47	126
José María Palazón Spain	6	106 1.7×	101 2.7×	43 1.5×	4 0.2×	1 0.1×	9	141
Lorena van den Bogaart Italy	7	6 0.1×	32 0.9×	17 0.6×	3 0.1×	7 0.4×	13	102
Fátima Aziz Spain	5	87 1.4×	85 2.3×	30 1.1×	1 0.0×	2 0.1×	11	141
Cristina Sánchez Spain	4	60 1.0×	72 1.9×	30 1.1×		2 0.1×	7	113

Countries citing papers authored by Mark Wong

Since Specialization

Citations

This map shows the geographic impact of Mark Wong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Wong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Wong more than expected).

Fields of papers citing papers by Mark Wong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Wong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Wong. The network helps show where Mark Wong may publish in the future.

Co-authorship network of co-authors of Mark Wong

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Wong. A scholar is included among the top collaborators of Mark Wong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Wong. Mark Wong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Pierce, Kyle C., et al.. (2024). S3866 An Unexpected Extraintestinal Manifestation of Ulcerative Colitis: Seronegative Necrotizing Myositis. The American Journal of Gastroenterology. 119(10S). S2525–S2525.

Wong, Mark, et al.. (2024). S4276 Pembrolizumab-Induced Hepatitis B Virus Resurgence Specifically in Asian Americans and Pacific Islanders. The American Journal of Gastroenterology. 119(10S). S2752–S2752.

Kang, Paul, et al.. (2020). Is 70 the new 50? Complications and outcomes of transjugular intrahepatic portosystemic shunt in older versus younger patients. Abdominal Radiology. 46(6). 2789–2794. 2 indexed citations

Kang, Paul, et al.. (2020). Rethink Your Transjugular Intrahepatic Portosystemic Shunt (TIPS): Pre-TIPS Infection Predicts Post-TIPS Infection and Post-TIPS Portosystemic Encephalopathy. 34–41. 1 indexed citations

Rowley, Michael, Amitkumar Patel, Wendi Zhou, Mark Wong, & Anil B. Seetharam. (2018). Immune Reconstitution Syndrome with Initiation of Treatment of HBV/HIV Co-infection: Activity Flare associated with E antigen Seroconversion. Annals of Hepatology. 18(1). 220–224. 10 indexed citations

Wong, Mark, et al.. (2018). Role of Rifaximin in Spontaneous Bacterial Peritonitis Prevention. Southern Medical Journal. 111(11). 660–665. 1 indexed citations

Wong, Mark, et al.. (2018). A Case of Hepatocellular Carcinoma (HCC) Immunotherapy Inducing Liver Transplant Rejection. The American Journal of Gastroenterology. 113(Supplement). S1347–S1347. 10 indexed citations

Patel, Amitkumar, et al.. (2017). Profiling Neutrophil–to–Lymphocyte Ratio Changes in Response to Nucleoside Analog Therapy for Chronic Hepatitis B Infection. In Vivo. 31(6). 1175–1177. 1 indexed citations

Little, Ester C., Richard Gerkin, Jeffrey Kahn, et al.. (2012). Coated Transjugular Intrahepatic Portosystemic Shunt Does Not Improve Thrombocytopenia in Patients with Liver Cirrhosis. Digestive Diseases and Sciences. 57(9). 2430–2437. 12 indexed citations

10.

Patel, Nayan, Mark Wong, Ester C. Little, et al.. (2008). Vibrio cholerae non‐O1 infection in cirrhotics: case report and literature review. Transplant Infectious Disease. 11(1). 54–56. 25 indexed citations

11.

Raschke, Robert, Steven C. Curry, Richard Gerkin, et al.. (2008). Results of a protocol for the management of patients with fulminant liver failure*. Critical Care Medicine. 36(8). 2244–2248. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact